Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference

LOUISVILLE, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1 investor meetings at the 2024 RBCCM Global Healthcare Conference, which will be held from May 14-15, 2024. 2024 RBCCM Global Healthcare Conference Fireside Chat Date: Tuesday, May 14, 2024 Fireside Chat Time: 1:35 PM ET Location: InterContinental New York